AG˹ٷ

STOCK TITAN

[Form 4] IREN Limited Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

IREN Limited (Ticker: IREN) filed a Form 4 detailing an insider equity award to Co-Chief Executive Officer and Director Daniel John Roberts.

  • Transaction date: 01 July 2025; filing signed 03 July 2025.
  • Security type: Ordinary Shares delivered via restricted stock units (RSUs).
  • Quantity granted: 1,793,392 RSUs at a stated price of $0, reflecting a compensation award rather than an open-market purchase.
  • Post-grant beneficial ownership: 14,989,696 ordinary shares held indirectly through Awassi Capital Trust #2, over which Roberts retains control.
  • The RSUs will vest only if the executive satisfies applicable vesting conditions; no further details on cliff or performance criteria were disclosed.

The filing signals continued equity-based compensation for senior management and marginally increases potential future share count by roughly 1.8 million shares once the RSUs vest and convert. Absent information on IREN’s total shares outstanding, the precise dilution impact cannot be quantified. Investors may view the award as aligning executive incentives with shareholder value, while also monitoring cumulative dilution from equity-based pay.

IREN Limited (Ticker: IREN) ha presentato un Modulo 4 che dettaglia un premio azionario interno al Co-Amministratore Delegato e Direttore Daniel John Roberts.

  • Data della transazione: 01 luglio 2025; deposito firmato il 03 luglio 2025.
  • Tipo di titolo: Azioni ordinarie consegnate tramite unità azionarie vincolate (RSU).
  • Quantità assegnata: 1.793.392 RSU a un prezzo indicato di $0, rappresentando un premio di compensazione e non un acquisto sul mercato aperto.
  • Possesso beneficiario dopo l’assegnazione: 14.989.696 azioni ordinarie detenute indirettamente tramite Awassi Capital Trust #2, sul quale Roberts mantiene il controllo.
  • Le RSU matureranno solo se l’esecutivo soddisferà le condizioni di maturazione applicabili; non sono stati forniti ulteriori dettagli su eventuali condizioni di vesting o criteri di performance.

Il deposito evidenzia la continuazione della remunerazione basata su azioni per il management senior e aumenta marginalmente il potenziale numero futuro di azioni di circa 1,8 milioni una volta che le RSU matureranno e si convertiranno. In assenza di informazioni sul totale delle azioni in circolazione di IREN, non è possibile quantificare con precisione l’impatto diluitivo. Gli investitori potrebbero interpretare il premio come un allineamento degli incentivi degli esecutivi con il valore per gli azionisti, monitorando al contempo la diluizione cumulativa derivante dalla remunerazione basata su azioni.

IREN Limited (Ticker: IREN) presentó un Formulario 4 detallando una concesión de acciones internas al Co-Director Ejecutivo y Director Daniel John Roberts.

  • Fecha de la transacción: 01 de julio de 2025; presentación firmada el 03 de julio de 2025.
  • Tipo de valor: Acciones ordinarias entregadas mediante unidades de acciones restringidas (RSUs).
  • Cantidad otorgada: 1,793,392 RSUs a un precio declarado de $0, reflejando un premio de compensación y no una compra en mercado abierto.
  • Propiedad beneficiaria después de la concesión: 14,989,696 acciones ordinarias mantenidas indirectamente a través de Awassi Capital Trust #2, sobre el cual Roberts mantiene control.
  • Las RSUs se consolidarán solo si el ejecutivo cumple con las condiciones de consolidación aplicables; no se divulgaron más detalles sobre criterios de vesting o desempeño.

La presentación indica una continuación de la compensación basada en acciones para la alta dirección y aumenta marginalmente el posible número futuro de acciones en aproximadamente 1.8 millones una vez que las RSUs se consoliden y conviertan. Sin información sobre el total de acciones en circulación de IREN, no se puede cuantificar con precisión el impacto dilutivo. Los inversores pueden ver el premio como un alineamiento de incentivos ejecutivos con el valor para los accionistas, mientras monitorean la dilución acumulada por la remuneración basada en acciones.

IREN Limited(티커: IREN)� 공동 최고경영� � 이사� Daniel John Roberts에게 내부� 주식 보상� 상세� 기재� Form 4� 제출했습니다.

  • 거래�: 2025� 7� 1�; 제출일은 2025� 7� 3� 서명�.
  • 증권 종류: 제한 주식 단위(RSUs)� 통해 지급된 보통�.
  • 부� 수량: 1,793,392 RSU, 명시 가격은 $0� 보상 목적으로 부여되었으� 공개 시장 매입� 아님.
  • 부� � 실질 소유�: Roberts가 통제하는 Awassi Capital Trust #2� 통해 ѫΪ적으� 보유 중인 14,989,696 보통�.
  • RSU� 임원� 해당 조건� 충족� 경우에만 베스팅되�, 베스� 기간이나 성과 기준� 관� 추가 정보� 공개되지 않았습니�.

이번 제출은 고위 경영진에 대� 주식 기반 보상� 계속되고 있음� 시사하며, RSU가 베스� � 전환� 경우 � 180� 주가 추가� 발행� 가능성� 소폭 증가시킵니다. IREN� � 발행 주식 수에 대� 정보가 없어 정확� 희석 효과� 산정� � 없습니다. 투자자들은 이번 보상� 경영진의 인센티브� 주주 가치와 일치시키� 조치� 보고, 주식 기반 보상으로 인한 누적 희석� 주시� � 있습니다.

IREN Limited (Ticker : IREN) a déposé un formulaire 4 détaillant une attribution d’actions internes au co-directeur général et administrateur Daniel John Roberts.

  • Date de la transaction : 1er juillet 2025 ; dépôt signé le 3 juillet 2025.
  • Type de titre : Actions ordinaires délivrées via des unités d’actions restreintes (RSU).
  • Quantité accordée : 1 793 392 RSU à un prix indiqué de 0 $, reflétant une attribution de rémunération plutôt qu’un achat sur le marché libre.
  • Propriété bénéficiaire après attribution : 14 989 696 actions ordinaires détenues indirectement par l’intermédiaire d’Awassi Capital Trust #2, sur lequel Roberts conserve le contrôle.
  • Les RSU ne seront acquises que si le dirigeant remplit les conditions d’acquisition applicables ; aucun détail supplémentaire sur les critères d’acquisition ou de performance n’a été communiqué.

Ce dépôt indique une poursuite de la rémunération en actions pour la haute direction et augmente légèrement le nombre potentiel d’actions futures d’environ 1,8 million une fois que les RSU seront acquises et converties. En l’absence d’informations sur le nombre total d’actions en circulation d’IREN, l’impact précis de la dilution ne peut être quantifié. Les investisseurs peuvent considérer cette attribution comme un alignement des incitations des dirigeants avec la valeur actionnariale, tout en surveillant la dilution cumulative liée à la rémunération en actions.

IREN Limited (Ticker: IREN) hat ein Formular 4 eingereicht, das eine Insider-Aktienzuteilung an den Co-CEO und Direktor Daniel John Roberts detailliert.

  • Transaktionsdatum: 01. Juli 2025; Einreichung unterschrieben am 03. Juli 2025.
  • Wertpapiertyp: Stammaktien, ausgegeben über Restricted Stock Units (RSUs).
  • Gewährte Menge: 1.793.392 RSUs zu einem angegebenen Preis von 0 $, was eine Vergütungsauszeichnung und keinen Marktkauf darstellt.
  • Nach der Zuteilung wirtschaftliches Eigentum: 14.989.696 Stammaktien, die indirekt über Awassi Capital Trust #2 gehalten werden, über den Roberts die Kontrolle behält.
  • Die RSUs werden nur dann unverfallbar, wenn der Manager die geltenden Vesting-Bedingungen erfüllt; keine weiteren Details zu Cliff- oder Leistungsanforderungen wurden offengelegt.

Die Einreichung signalisiert eine fortgesetzte aktienbasierte Vergütung für das obere Management und erhöht die potenzielle zukünftige Aktienanzahl um etwa 1,8 Millionen Aktien, sobald die RSUs unverfallbar werden und umgewandelt sind. Ohne Angaben zur Gesamtzahl der ausstehenden IREN-Aktien kann die genaue Verwässerungswirkung nicht beziffert werden. Investoren könnten die Auszeichnung als eine Angleichung der Anreize des Managements an den Aktionärswert sehen, während sie die kumulative Verwässerung durch aktienbasierte Vergütung beobachten.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine RSU grant increases Co-CEO’s indirect stake to 14.99 M shares; dilution modest, governance neutral.

The 1.79 M-unit RSU award represents a non-cash compensation expense and has no immediate cash impact. Because the units convert at $0, they will expand share count upon vesting. If IREN’s float is large (>100 M), the dilution is roughly 1�2 %; otherwise impact rises. The award keeps Roberts� economic interests aligned with shareholders, a mild positive from an agency-cost standpoint. No insider selling occurred, so the filing does not carry a negative sentiment signal. Overall market impact should be limited unless the company’s equity compensation trend accelerates.

TL;DR: Equity-heavy pay mix reinforces alignment but adds future dilution risk; impact neutral-to-slightly positive.

Granting nearly 1.8 M RSUs to a sitting Co-CEO indicates the board prioritises long-term, equity-based incentives. Because the RSUs are held via a controlled trust, governance standards for disclosure are met, and the executive disclaims beneficial ownership beyond pecuniary interests, limiting related-party concerns. Investors should request clarity on vesting triggers to verify they are performance-based rather than time-based. Without such information, dilution could occur regardless of outcome achievement. Nonetheless, maintaining a significant insider stake (�15 M shares) can align decision-making with shareholder value creation. I assign a neutral rating given balanced pros and cons.

IREN Limited (Ticker: IREN) ha presentato un Modulo 4 che dettaglia un premio azionario interno al Co-Amministratore Delegato e Direttore Daniel John Roberts.

  • Data della transazione: 01 luglio 2025; deposito firmato il 03 luglio 2025.
  • Tipo di titolo: Azioni ordinarie consegnate tramite unità azionarie vincolate (RSU).
  • Quantità assegnata: 1.793.392 RSU a un prezzo indicato di $0, rappresentando un premio di compensazione e non un acquisto sul mercato aperto.
  • Possesso beneficiario dopo l’assegnazione: 14.989.696 azioni ordinarie detenute indirettamente tramite Awassi Capital Trust #2, sul quale Roberts mantiene il controllo.
  • Le RSU matureranno solo se l’esecutivo soddisferà le condizioni di maturazione applicabili; non sono stati forniti ulteriori dettagli su eventuali condizioni di vesting o criteri di performance.

Il deposito evidenzia la continuazione della remunerazione basata su azioni per il management senior e aumenta marginalmente il potenziale numero futuro di azioni di circa 1,8 milioni una volta che le RSU matureranno e si convertiranno. In assenza di informazioni sul totale delle azioni in circolazione di IREN, non è possibile quantificare con precisione l’impatto diluitivo. Gli investitori potrebbero interpretare il premio come un allineamento degli incentivi degli esecutivi con il valore per gli azionisti, monitorando al contempo la diluizione cumulativa derivante dalla remunerazione basata su azioni.

IREN Limited (Ticker: IREN) presentó un Formulario 4 detallando una concesión de acciones internas al Co-Director Ejecutivo y Director Daniel John Roberts.

  • Fecha de la transacción: 01 de julio de 2025; presentación firmada el 03 de julio de 2025.
  • Tipo de valor: Acciones ordinarias entregadas mediante unidades de acciones restringidas (RSUs).
  • Cantidad otorgada: 1,793,392 RSUs a un precio declarado de $0, reflejando un premio de compensación y no una compra en mercado abierto.
  • Propiedad beneficiaria después de la concesión: 14,989,696 acciones ordinarias mantenidas indirectamente a través de Awassi Capital Trust #2, sobre el cual Roberts mantiene control.
  • Las RSUs se consolidarán solo si el ejecutivo cumple con las condiciones de consolidación aplicables; no se divulgaron más detalles sobre criterios de vesting o desempeño.

La presentación indica una continuación de la compensación basada en acciones para la alta dirección y aumenta marginalmente el posible número futuro de acciones en aproximadamente 1.8 millones una vez que las RSUs se consoliden y conviertan. Sin información sobre el total de acciones en circulación de IREN, no se puede cuantificar con precisión el impacto dilutivo. Los inversores pueden ver el premio como un alineamiento de incentivos ejecutivos con el valor para los accionistas, mientras monitorean la dilución acumulada por la remuneración basada en acciones.

IREN Limited(티커: IREN)� 공동 최고경영� � 이사� Daniel John Roberts에게 내부� 주식 보상� 상세� 기재� Form 4� 제출했습니다.

  • 거래�: 2025� 7� 1�; 제출일은 2025� 7� 3� 서명�.
  • 증권 종류: 제한 주식 단위(RSUs)� 통해 지급된 보통�.
  • 부� 수량: 1,793,392 RSU, 명시 가격은 $0� 보상 목적으로 부여되었으� 공개 시장 매입� 아님.
  • 부� � 실질 소유�: Roberts가 통제하는 Awassi Capital Trust #2� 통해 ѫΪ적으� 보유 중인 14,989,696 보통�.
  • RSU� 임원� 해당 조건� 충족� 경우에만 베스팅되�, 베스� 기간이나 성과 기준� 관� 추가 정보� 공개되지 않았습니�.

이번 제출은 고위 경영진에 대� 주식 기반 보상� 계속되고 있음� 시사하며, RSU가 베스� � 전환� 경우 � 180� 주가 추가� 발행� 가능성� 소폭 증가시킵니다. IREN� � 발행 주식 수에 대� 정보가 없어 정확� 희석 효과� 산정� � 없습니다. 투자자들은 이번 보상� 경영진의 인센티브� 주주 가치와 일치시키� 조치� 보고, 주식 기반 보상으로 인한 누적 희석� 주시� � 있습니다.

IREN Limited (Ticker : IREN) a déposé un formulaire 4 détaillant une attribution d’actions internes au co-directeur général et administrateur Daniel John Roberts.

  • Date de la transaction : 1er juillet 2025 ; dépôt signé le 3 juillet 2025.
  • Type de titre : Actions ordinaires délivrées via des unités d’actions restreintes (RSU).
  • Quantité accordée : 1 793 392 RSU à un prix indiqué de 0 $, reflétant une attribution de rémunération plutôt qu’un achat sur le marché libre.
  • Propriété bénéficiaire après attribution : 14 989 696 actions ordinaires détenues indirectement par l’intermédiaire d’Awassi Capital Trust #2, sur lequel Roberts conserve le contrôle.
  • Les RSU ne seront acquises que si le dirigeant remplit les conditions d’acquisition applicables ; aucun détail supplémentaire sur les critères d’acquisition ou de performance n’a été communiqué.

Ce dépôt indique une poursuite de la rémunération en actions pour la haute direction et augmente légèrement le nombre potentiel d’actions futures d’environ 1,8 million une fois que les RSU seront acquises et converties. En l’absence d’informations sur le nombre total d’actions en circulation d’IREN, l’impact précis de la dilution ne peut être quantifié. Les investisseurs peuvent considérer cette attribution comme un alignement des incitations des dirigeants avec la valeur actionnariale, tout en surveillant la dilution cumulative liée à la rémunération en actions.

IREN Limited (Ticker: IREN) hat ein Formular 4 eingereicht, das eine Insider-Aktienzuteilung an den Co-CEO und Direktor Daniel John Roberts detailliert.

  • Transaktionsdatum: 01. Juli 2025; Einreichung unterschrieben am 03. Juli 2025.
  • Wertpapiertyp: Stammaktien, ausgegeben über Restricted Stock Units (RSUs).
  • Gewährte Menge: 1.793.392 RSUs zu einem angegebenen Preis von 0 $, was eine Vergütungsauszeichnung und keinen Marktkauf darstellt.
  • Nach der Zuteilung wirtschaftliches Eigentum: 14.989.696 Stammaktien, die indirekt über Awassi Capital Trust #2 gehalten werden, über den Roberts die Kontrolle behält.
  • Die RSUs werden nur dann unverfallbar, wenn der Manager die geltenden Vesting-Bedingungen erfüllt; keine weiteren Details zu Cliff- oder Leistungsanforderungen wurden offengelegt.

Die Einreichung signalisiert eine fortgesetzte aktienbasierte Vergütung für das obere Management und erhöht die potenzielle zukünftige Aktienanzahl um etwa 1,8 Millionen Aktien, sobald die RSUs unverfallbar werden und umgewandelt sind. Ohne Angaben zur Gesamtzahl der ausstehenden IREN-Aktien kann die genaue Verwässerungswirkung nicht beziffert werden. Investoren könnten die Auszeichnung als eine Angleichung der Anreize des Managements an den Aktionärswert sehen, während sie die kumulative Verwässerung durch aktienbasierte Vergütung beobachten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Roberts Daniel John

(Last) (First) (Middle)
C/O IREN LIMITED
LEVEL 6, 55 MARKET STREET

(Street)
SYDNEY C3 2000

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IREN Ltd [ IREN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Co-Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 07/01/2025 A 1,793,392(1) A $0 14,989,696 I By Awassi Capital Trust #2(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of restricted stock units ("RSUs") that will vest subject to the Reporting Person's satisfaction of applicable vesting conditions.
2. Represents ordinary shares of IREN Limited (each, an "Ordinary Share") and RSUs held through the Awassi Capital Trust #2, of which the Reporting Person has control over the trustee. The Reporting Person disclaims beneficial ownership of the Ordinary Shares and RSUs except to the extent of his pecuniary interest therein.
/s/ Cesilia Kim, attorney-in-fact for Daniel Roberts 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Co-CEO Daniel Roberts report in the July 2025 Form 4 for IREN?

He was granted 1,793,392 restricted stock units convertible into ordinary shares at a price of $0.

How many IREN shares does Daniel Roberts beneficially own after the RSU grant?

Following the transaction, his indirect stake totals 14,989,696 ordinary shares held via Awassi Capital Trust #2.

Did the RSU grant involve any cash outlay or exercise price?

No. The RSUs were granted at a $0 conversion price, reflecting a compensation award.

When were the RSUs granted and when was the Form 4 signed?

The grant date is 01 July 2025; the Form 4 was signed on 03 July 2025.

Through which entity does Daniel Roberts hold his IREN shares?

Shares and RSUs are held indirectly via Awassi Capital Trust #2, over which Roberts controls the trustee.
IREN Ltd

NASDAQ:IREN

IREN Rankings

IREN Latest News

IREN Latest SEC Filings

IREN Stock Data

3.17B
214.60M
6.43%
46.18%
10.16%
Capital Markets
Financial Services
Australia
Sydney